Table 4.

Asthma progression (measured as the intensity of asthma medication use) in the SLIT and non‐AIT groups over the various time periods

Asthma prescriptions per patient per annum	Mean±SD	Range	Median [IQR]
Preindex period
SLIT group	3.38±2.72	1‐28	3 [2‐4]
Non‐AIT group	3.00±2.30	1‐40	2 [1‐4]
Treatment period
SLIT group	2.97±3.46	0‐23.43	1.84 [0.66‐4.08]
Non‐AIT group	2.94±2.82	0‐45.30	2.27 [1.00‐4.14]
Follow‐up period
SLIT group	0.68±1.63	0‐12.99	0 [0‐0.53]
Non‐AIT group	1.13±2.32	0‐98.83	0.41 [0‐1.29]
Full analysis period (treatment+follow‐up)
SLIT group	1.47±1.94	0‐16.59	0.78 [0.31‐1.84]
Non‐AIT group	1.55±2.10	0‐75.58	0.92 [0.41‐1.93]

AIT, allergy immunotherapy; SLIT, sublingual immunotherapy.